09 May, 2026

Biotech raises $42 million to run Huntington’s disease trial

Allison DeAngelis is an East Coast biotechnology and venture reporter at STAT, where science ideas and money collide. She is also co-host of the weekly biotechnology podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. Gene therapy startup Latus Bio has raised another $42 million to launch its first clinical trials, in […]

2 mins read

New Grail cancer test data shows progress but raises questions

As part of its bid to transform the future of cancer screening and take control of a potentially large and increasingly competitive market, Grail on Friday announced new data from a large U.S. study of its flagship blood test for detecting dozens of tumor types. The results reinforce some of the company’s arguments for a […]

1 min read